Maravai LifeSciences Holdings, Inc. (MRVI) Return on equity 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-61.6%FY2025 · since FY2019: -3.1% → -61.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -61.6% | -17.1 pp |
| FY2024 | -44.5% | -11.3 pp |
| FY2023 | -33.2% | -123.2 pp |
| FY2022 | 90.0% | -58.7 pp |
| FY2021 | 148.7% | +48.2 pp |
| FY2020 | 100.5% | +103.6 pp |
| FY2019 | -3.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice